In addition, we observed a significant reduction in cleaved caspase 3 immunoreactivity in tumors from LPS-treated groups compared to the Dox responder group (Figure 5M), suggesting that LPS signaling reduces Dox-mediated apoptotic signaling to reduce chemotherapy anti-cancer response. Here, CASP3 is linked to cancer.